Blueprint Investment Partners’s Gilead Sciences GILD Stock Holding History

Blueprint Investment Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,771	Closed	-$625K	–	138
2024 Q4	$625K	Buy	6,771 +2,537	+60%	+$228K	0.1%	109
2024 Q3	$355K	Buy	+4,234	New	+$323K	0.06%	126
2024 Q1	–	Sell	-4,872	Closed	-$395K	–	146
2023 Q4	$395K	Buy	+4,872	New	+$379K	0.11%	83
2023 Q3	–	Sell	-5,864	Closed	-$452K	–	121
2023 Q2	$452K	Sell	5,864 -2,411	-29%	-$192K	0.16%	90
2023 Q1	$687K	Sell	8,275 -3,130	-27%	-$259K	0.16%	87
2022 Q4	$979K	Buy	11,405 +7,729	+210%	+$612K	0.21%	80
2022 Q3	$227K	Sell	3,676 -1,137	-24%	-$71.7K	0.06%	123
2022 Q2	$297K	Buy	+4,813	New	+$298K	0.08%	111
2022 Q1	–	Sell	-8,103	Closed	-$588K	–	225
2021 Q4	$588K	Buy	8,103 +2,671	+49%	+$184K	0.14%	111
2021 Q3	$379K	Buy	+5,432	New	+$382K	0.19%	80

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Blueprint Investment Partners's GILD Position: Q1 2025 in Review

Blueprint Investment Partners sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 6,771 shares — an estimated $625K sold.

Blueprint Investment Partners first reported a position in GILD in Q3 2021 and held it in 10 quarters. The position peaked at $979K in Q4 2022. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

Blueprint Investment Partners reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
Blueprint Investment Partners sold 6,771 Gilead Sciences shares in Q1 2025, an estimated $625K.
Blueprint Investment Partners first reported a position in Gilead Sciences in Q3 2021 and held it in 10 quarters.
Blueprint Investment Partners's Gilead Sciences position peaked at $979K in Q4 2022.
2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Blueprint Investment Partners's 13F filing for Q1 2025, filed 12 May 2025.